Electrochemical characterization of repaglinide and its determination in human plasma using liquid chromatography with dual-channel coulometric detection

被引:9
作者
Jirovsky, David [1 ]
Bartosova, Zdenka [1 ]
Skopalova, Jana [1 ]
Maier, Vitezslav [1 ]
机构
[1] Palacky Univ, Dept Analyt Chem, CZ-77146 Olomouc, Czech Republic
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2010年 / 878卷 / 31期
关键词
Repaglinide; Rosiglitazone; HPLC; Coulometric detection; Peroral antidiabetics; Plasma; TYPE-2; DIABETES-MELLITUS; ANTIDIABETIC AGENT; HPLC; PHARMACOKINETICS; BIOAVAILABILITY; ROSIGLITAZONE; IONIZATION; MANAGEMENT; DRUGS; ARRAY;
D O I
10.1016/j.jchromb.2010.09.029
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A simple fast and sensitive HPLC method employing dual-channel coulometric detection for the determination of repaglinide in human plasma is presented The assay involved extraction of repaglinide by ethyl acetate and isocratic reversed-phase liquid chromatography with dual-channel coulometric detection The mobile phase composition was 50mM disodium hydrogen phosphate/acetonitrile (60 40 v/v) pH of the mobile phase 7 5 set up with phosphoric acid For all analyses the first cell working potential was +380 mV the second was +750 mV (vs Pd/H-2) Calibration curve was linear over the concentration range of 5-500 nmol L-1 Rosiglitazone was used as an internal standard The limit of detection CLOD) was established at 28 nmol L-1 and the lower limit of quantification (LLOQ) at 85 nmol L-1 The developed method was applied to human plasma samples spiked with repaglinide at therapeutical concentrations It was confirmed that the method is suitable for pharmacokinetic studies or therapeutic monitoring (C) 2010 Elsevier B V All rights reserved
引用
收藏
页码:3243 / 3248
页数:6
相关论文
共 26 条
  • [11] Changes in age at diagnosis of type 2 diabetes mellitus in the United States, 1988 to 2000
    Koopman, RJ
    Mainous, AG
    Diaz, VA
    Geesey, ME
    [J]. ANNALS OF FAMILY MEDICINE, 2005, 3 (01) : 60 - 69
  • [12] Determination of antihyperglycemic drugs in nanomolar concentration levels by micellar electrokinetic chromatography with non-ionic surfactant
    Maier, Vitezslav
    Znaleziona, Joanna
    Jirovsky, David
    Skopalova, Jana
    Petr, Jan
    Sevcik, Juraj
    [J]. JOURNAL OF CHROMATOGRAPHY A, 2009, 1216 (20) : 4492 - 4498
  • [13] Ionization, lipophilicity and solubility properties of repaglinide
    Mandic, Z
    Gabelica, V
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2006, 41 (03) : 866 - 871
  • [14] Hypoglycaemic effects of the novel antidiabetic agent repaglinide in rats and dogs
    Mark, M
    Grell, W
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1997, 121 (08) : 1597 - 1604
  • [15] Oliver S, 1997, DIABETES, V46, P1263
  • [16] Owens DR, 1998, DIABETIC MED, V15, pS28, DOI 10.1002/(SICI)1096-9136(1998120)15:4+<S28::AID-DIA748>3.3.CO
  • [17] 2-K
  • [18] OZKAN SA, 2007, CHROMATOGRAPHIA, V66, P53
  • [19] Repaglinide - A pharmacoeconomic review of its use in type 2 diabetes mellitus
    Plosker, GL
    Figgitt, DP
    [J]. PHARMACOECONOMICS, 2004, 22 (06) : 389 - 411
  • [20] Plum A, 2000, METHOD FIND EXP CLIN, V22, P139